Sort
23,748 grants matching “melanoma”
EZH2 in cancer biology and novel inhibitors
$492,047Jun Qi · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$492,027Thomas G Graeber · University Of California Los Angeles · P01 · FY2024 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$492,026Roger S Lo · University Of California Los Angeles · P01 · FY2024 · CA
Project 3: Modeling and overcoming resistance to melanoma immunotherapy
$492,024Antoni Ribas · University Of California Los Angeles · P01 · FY2024 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$491,992William R Roush · Scripps Florida · R01 · FY2015 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$491,992William R Roush · Scripps Florida · R01 · FY2016 · CA
5500 QTrap Mass Spectrometer for Yale University, Keck Laboratory
$491,747Christopher Michael Colangelo · Yale University · S10 · FY2010 · RR
Tailored Intervention for Melanoma Patients'Families
$491,585Fox Chase Cancer Center · R01 · FY2005 · CA
Personalized Immunotherapy of Patients with Ovarian Cancer
$491,531Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
Renalase inhibition for treatment of unresectable melanoma
$491,209Harriet M Kluger · Yale University · R01 · FY2018 · CA
The Adenosinergic Pathway in Tumor-derived Exosomes
$491,088Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
THERAPEUTIC MANUFACTURING
$490,937Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2013 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$490,853Benjamin W. Purow · University Of Virginia · R01 · FY2017 · CA
Characterization of Cancer Stem Cells
$490,842William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$490,839Chad A. Mirkin · Northwestern University · R01 · FY2024 · CA
The role of Staphylococcus aureus aggregate formation in establishing biofilms in chronic orthopaedic periprosthetic joint infection.
$490,778Paul Stoodley · Ohio State University · R01 · FY2020 · GM
The role of Staphylococcus aureus aggregate formation in establishing biofilms in chronic orthopaedic periprosthetic joint infection.
$490,778Paul Stoodley · Ohio State University · R01 · FY2021 · GM
The role of Staphylococcus aureus aggregate formation in establishing biofilms in chronic orthopaedic periprosthetic joint infection.
$490,778Paul Stoodley · Ohio State University · R01 · FY2019 · GM
Microbiota-Immune Interactions in CTLA-4 Antibody Blockade-Induced Colitis
$490,725Gabriel Nunez · University Of Michigan At Ann Arbor · R01 · FY2024 · DK
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2024 · AI
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2025 · AI
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2023 · AI
MDA-7/IL-24: Therapy of Prostate Cancer
$490,383Paul B Fisher · Virginia Commonwealth University · P01 · FY2009 · CA
Renalase inhibition for treatment of unresectable melanoma
$490,257Harriet M Kluger · Yale University · R01 · FY2017 · CA
CTLA-4 Inhibition and Autoimmunity in Melanoma
$490,127Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2007 · CA